Yüklüyor......
Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double‐blind, 8‐week study
A majority of patients with hypertension fail to achieve blood pressure (BP) control despite treatment with commonly prescribed drugs. This randomized, double‐blind phase III trial assessed the superiority of sacubitril/valsartan 200 mg (97/103 mg) to continued olmesartan 20 mg in reducing ambulator...
Kaydedildi:
| Yayımlandı: | J Clin Hypertens (Greenwich) |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8031201/ https://ncbi.nlm.nih.gov/pubmed/29338113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.13153 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|